275
Views
12
Downloads
48
Crossref
N/A
WoS
45
Scopus
0
CSCD
In view of the potential of polymethoxyflavones (PMFs) and hydroxylated PMFs (OH-PMFs) as bioactives against inflammation, we prepared six different orange peel extracts (OPEs). The major compounds of these extracts were characterized and quantified by high performance liquid chromatography (HPLC). Effects on inflammation were analyzed by nutrigenomics using a human cell-based TPA-induced monocyte–macrophage differentiation model employing U-937 cells and inflammatory surrogate genes. Dose response and kinetics analysis of OPEs with different chemical profiles revealed less cytotoxic effects of PMFs as compared to OH-PMFs as demonstrated by the MTT-method. Noteworthy, a comparison of two PMF members such as 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF) and 3,5,6,7,8,3′,4′-heptamethoxyflavone (HeptaMF) exhibited less cytotoxic effects of HeptaMF as compared to HexaMF. A specific OPE enriched with HeptaMF, PMFs and OH-PMFs at low concentrations (10 μg/mL) significantly down-regulated the expression of a panel of genes involved in inflammatory response, including COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6, and IL-8 with an inflammatory index of −0.55. The strong anti-inflammatory effects were then validated in a mouse carrageenan-induced paw edema model. Oral intake of OPE reduced paw edema significantly in a dose-dependent manner. Importantly, a dosage of 250 mg/kg gave an anti-inflammatory effect comparable to ibuprofen. A preliminary clinical study showed that OPE was well tolerated showing no adverse side effects. In summary, enrichment of phyto extracts such as OPEs with specific polymethoxyflavones as anti-inflammatory bioactives is a promising strategy to find naturally derived extracts that are effective against diseases associated with inflammation.
In view of the potential of polymethoxyflavones (PMFs) and hydroxylated PMFs (OH-PMFs) as bioactives against inflammation, we prepared six different orange peel extracts (OPEs). The major compounds of these extracts were characterized and quantified by high performance liquid chromatography (HPLC). Effects on inflammation were analyzed by nutrigenomics using a human cell-based TPA-induced monocyte–macrophage differentiation model employing U-937 cells and inflammatory surrogate genes. Dose response and kinetics analysis of OPEs with different chemical profiles revealed less cytotoxic effects of PMFs as compared to OH-PMFs as demonstrated by the MTT-method. Noteworthy, a comparison of two PMF members such as 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF) and 3,5,6,7,8,3′,4′-heptamethoxyflavone (HeptaMF) exhibited less cytotoxic effects of HeptaMF as compared to HexaMF. A specific OPE enriched with HeptaMF, PMFs and OH-PMFs at low concentrations (10 μg/mL) significantly down-regulated the expression of a panel of genes involved in inflammatory response, including COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6, and IL-8 with an inflammatory index of −0.55. The strong anti-inflammatory effects were then validated in a mouse carrageenan-induced paw edema model. Oral intake of OPE reduced paw edema significantly in a dose-dependent manner. Importantly, a dosage of 250 mg/kg gave an anti-inflammatory effect comparable to ibuprofen. A preliminary clinical study showed that OPE was well tolerated showing no adverse side effects. In summary, enrichment of phyto extracts such as OPEs with specific polymethoxyflavones as anti-inflammatory bioactives is a promising strategy to find naturally derived extracts that are effective against diseases associated with inflammation.
J.K. Kundu, Y.J. Surh, Inflammation: gearing the journey to cancer, Mutat. Res. 659 (2008) 15–30.
B.B. Aggarwal, S. Krishnan, S. Guha, Inflammation, Lifestyle and Chronic Diseases: The Silent Link (Oxidative Stress and Disease), CRC Press, Boca Raton, 2012.
Z.A. Radi, M.R. Ackermann, Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration, J. Vet. Intern. Med. 15 (2001) 516–529.
S. Ghosh, M.S. Hayden, New regulators of NF-kappaB in inflammation, Nat. Rev. Immunol. 8 (2008) 837–848.
A. Gosslau, S. Li, C.T. Ho, The importance of natural product characterization in studies of their anti-inflammatory activity, Mol. Nutr. Food Res. 55 (2011) 74–82.
M.-H. Pan, S. Li, C.-S. Lai, et al., Inhibition of citrus flavonoids on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumorigenesis in mice, Food Sci. Human Wellness 1 (2012) 65–73.
J.A. Manthey, K. Grohmann, A. Montanari, et al., Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes, J. Nat. Prod. 62 (1999) 441–444.
J.P. Bastard, M. Maachi, C. Lagathu, et al., Recent advances in the relationship between obesity, inflammation, and insulin resistance, Eur. Cytokine Netw. 17 (2006) 4–12.
N. Lin, T. Sato, Y. Takayama, et al., Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages, Biochem. Pharmacol. 65 (2003) 2065–2071.
S.Y. Choi, H.C. Ko, S.Y. Ko, et al., Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits, Biol. Pharm. Bull. 30 (2007) 772–778.
K.E. Malterud, K.M. Rydland, Inhibitors of 15-lipoxygenase from orange peel, J. Agric. Food Chem. 48 (2000) 5576–5580.
S. Li, S. Sang, M.H. Pan, et al., Anti-inflammatory property of the urinary metabolites of nobiletin in mouse, Bioorg. Med. Chem. Lett. 17 (2007) 5177–5181.
A. Murakami, Y. Nakamura, K. Torikai, et al., Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice, Cancer Res. 60 (2000) 5059–5066.
I.N. Sergeev, C.T. Ho, S. Li, et al., Apoptosis-inducing activity of hydroxylated polymethoxyflavones and polymethoxyflavones from orange peel in human breast cancer cells, Mol. Nutr. Food Res. 51 (2007) 1478–1484.
A. Murakami, T. Shigemori, H. Ohigashi, Zingiberaceous and citrus constituents, 1′-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action, J. Nutr. 135 (2005) 2987S–2992S.
S. Tanaka, T. Sato, N. Akimoto, et al., Prevention of UVB-induced photoinflammation and photoaging by a polymethoxy flavonoid, nobiletin, in human keratinocytes in vivo and in vitro, Biochem. Pharmacol. 68 (2004) 433–439.
J.A. Manthey, P. Bendele, Anti-inflammatory activity of an orange peel polymethoxylated flavone, 3′,4′,3,5,6,7,8-heptamethoxyflavone, in the rat carrageenan/paw edema and mouse lipopolysaccharide-challenge assays, J. Agric. Food Chem. 56 (2008) 9399–9403.
C.S. Lai, S. Li, C.Y. Chai, et al., Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3′,4′-didemethylnobiletin, derived from nobiletin, Carcinogenesis 29 (2008) 2415–2424.
C.S. Lai, M.L. Tsai, A.C. Cheng, et al., Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane-treated mice, Mol. Nutr. Food Res. 55 (2010) 278–290.
S. Li, M.-H. Pan, C.-Y. Lo, et al., Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones, J. Funct. Foods 1 (2009) 2–12.
M. Muller, S. Kersten, Nutrigenomics: goals and strategies, Nat. Rev. Genet. 4 (2003) 315–322.
V. Garcia-Canas, C. Simo, C. Leon, Advances in nutrigenomics research: novel and future analytical approaches to investigate the biological activity of natural compounds and food functions, J. Pharm. Biomed. Anal. 51 (2010) 290–304.
S. Li, C.Y. Lo, C.T. Ho, Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel, J. Agric. Food Chem. 54 (2006) 4176–4185.
K. Berg, M. Hansen, S. Nielsen, A new sensitive bioassay for precise quantification of interferon activity as measured via the mitochondrial dehydrogenase function in cells (MTT-method), APMIS 98 (1990) 156–162.
D. Bernhard, W. Schwaiger, R. Crazzolara, et al., Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells, Cancer Lett. 195 (2003) 193–199.
A. Gosslau, M. Chen, C. Ho, K. Chen, A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts, Br. J. Cancer 92 (2005) 513–521.
A.N. Raick, Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoyl-phorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion, Cancer Res. 33 (1973) 269–286.
T. Nakadate, The mechanism of skin tumor promotion caused by phorbol esters: possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems, Jpn. J. Pharmacol. 49 (1989) 1–9.
K. Forsbeck, K. Nilsson, A. Hansson, et al., Phorbol ester-induced alteration of differentiation and proliferation in human hematopoietic tumor cell lines: relationship to the presence and subcellular distribution of protein kinase C, Cancer Res. 45 (1985) 6194–6199.
A. Gosslau, S. Sisk, M.-T. Huang, et al., Case study of an anti-inflammatory ingredient discovered via nutrigenomic screening, J. Nutrigenet. Nutrigenomics 1 (2008) 76–77.
A. Gosslau, D.L. En Jao, M.T. Huang, et al., Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo, Mol. Nutr. Food Res. 55 (2011) 198–208.
C.J. Morris, Carrageenan-induced paw edema in the rat and mouse, Methods Mol. Biol. 225 (2003) 115–121.
L.J. Moilanen, M. Laavola, M. Kukkonen, et al., TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse, Sci. Rep. 2 (2012) 380.
Z. Wang, S. Li, S. Ferguson, et al., Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts, J. Sep. Sci. 31 (2008) 30–37.
W.L. Smith, D.L. DeWitt, R.M. Garavito, Cyclooxygenases: structural, cellular, and molecular biology, Annu. Rev. Biochem. 69 (2000) 145–182.
S. Zha, V. Yegnasubramanian, W.G. Nelson, et al., Cyclooxygenases in cancer: progress and perspective, Cancer Lett. 215 (2004) 1–20.
I.N. Sergeev, S. Li, J. Colby, et al., Polymethoxylated flavones induce Ca2+-mediated apoptosis in breast cancer cells, Life Sci. 80 (2006) 245–253.
A.N. Raick, K. Thumm, B.R. Chivers, Early effects of 12-O-tetradecanoyl-phorbol-13-acetate on the incorporation of tritiated precursor into DNA and the thickness of the interfollicular epidermis, and their relation to tumor promotion in mouse skin, Cancer Res. 32 (1972) 1562–1568.
V. Baud, M. Karin, Is NF-κB a good target for cancer therapy? Hopes and pitfalls, Nat. Rev. Drug Discov. 8 (2009) 33–40.
B.B. Aggarwal, P. Gehlot, Inflammation and cancer: how friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 9 (2009) 351–369.
The authors wish to thank WellGen Inc. for support of materials.